Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Mosaic's Q2 Earnings and Revenues Miss, Phosphate Volumes Fall
Mosaic's Q2 Earnings and Revenues Miss, Phosphate Volumes Fall

The Mosaic Company MOS reported a net profit of $411 million or $1.29 per share for the second quarter of 2025. This marks an upside from a loss of $162 million or 50 cents per share in the year-ago

Jones Lang LaSalle (JLL) Beats Q2 Earnings and Revenue Estimates
Jones Lang LaSalle (JLL) Beats Q2 Earnings and Revenue Estimates

Jones Lang LaSalle (JLL) came out with quarterly earnings of $3.3 per share, beating the Zacks Consensus Estimate of $3.2 per share. This compares to earnings of $2.55 per share a year ago. These

Griffon (GFF) Q3 Earnings Meet Estimates
Griffon (GFF) Q3 Earnings Meet Estimates

Griffon (GFF) came out with quarterly earnings of $1.5 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.24 per share a year ago. These figures are adjusted for

Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates
Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates

Lexicon Pharmaceuticals (LXRX) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.17 per share a

eHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
eHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates

eHealth (EHTH) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to a loss of $1.09 per share a year ago. These figures are

Arista Beats Q2 Earnings Estimates on Healthy Top-Line Growth
Arista Beats Q2 Earnings Estimates on Healthy Top-Line Growth

Arista Networks, Inc. ANET reported strong second-quarter 2025 results, with revenues and adjusted earnings soaring year over year, driven by robust demand trends. Innovative product launches and

Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy

Hims & Hers' (NYSE: HIMS) August price dip is an opportunity to buy, but investors shouldn’t rush to get into this healthcare stock. Forces in play, including high short interest and tepid

Will JPMorgan-Coinbase Tie-Up Bring Crypto Closer to Mainstream?
Will JPMorgan-Coinbase Tie-Up Bring Crypto Closer to Mainstream?

The partnership between JPMorgan JPM and Coinbase Global COIN marks a pivotal step toward mainstream cryptocurrency adoption in the United States, combining the strengths of a leading global bank

Payoneer Global Inc. (PAYO) Q2 Earnings Lag Estimates
Payoneer Global Inc. (PAYO) Q2 Earnings Lag Estimates

Payoneer Global Inc. (PAYO) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.09 per share a year ago

Sunstone Hotel Investors (SHO) Q2 FFO and Revenues Surpass Estimates
Sunstone Hotel Investors (SHO) Q2 FFO and Revenues Surpass Estimates

Sunstone Hotel Investors (SHO) came out with quarterly funds from operations (FFO) of $0.28 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to FFO of $0.28 per

Gibraltar Industries (ROCK) Q2 Earnings and Revenues Lag Estimates
Gibraltar Industries (ROCK) Q2 Earnings and Revenues Lag Estimates

Gibraltar Industries (ROCK) came out with quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.18 per share a year ago

Holley Inc. (HLLY) Q2 Earnings Miss Estimates
Holley Inc. (HLLY) Q2 Earnings Miss Estimates

Holley Inc. (HLLY) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.1 per share a year ago. These figures

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

Arbutus Biopharma (ABUS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.11 per share a year

Best Income Stocks to Buy for August 6th
Best Income Stocks to Buy for August 6th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, August 6th:

Tsakos Energy Navigation Ltd TEN: This company which is a leading provider of

Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks
Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks

The U.S. market slid slightly yesterday as investors weighed fresh earnings reports, economic data and tariff news. President Trump will be announcing new tariffs on semiconductor and pharmaceutical

Chevy Equinox EV Tops Non-Tesla Charts: Can GM Keep the Lead?
Chevy Equinox EV Tops Non-Tesla Charts: Can GM Keep the Lead?

General Motors GM had a strong showing in the EV space last month, led by the Chevrolet Equinox EV. The electric SUV didn’t just have its best month ever—it became the top-selling non-Tesla EV in

New York Times Co. (NYT) Q2 Earnings and Revenues Beat Estimates
New York Times Co. (NYT) Q2 Earnings and Revenues Beat Estimates

New York Times Co. (NYT) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.45 per share a year ago. These

Telesat (TSAT) Tops Q2 Earnings Estimates
Telesat (TSAT) Tops Q2 Earnings Estimates

Telesat (TSAT) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of a loss of $0.69 per share. This compares to a loss of $2.87 per share a year ago. These

Kornit Digital (KRNT) Q2 Earnings Top Estimates
Kornit Digital (KRNT) Q2 Earnings Top Estimates

Kornit Digital (KRNT) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago. These

Archrock Beats on Q2 Earnings & Revenues, Raises '25 View
Archrock Beats on Q2 Earnings & Revenues, Raises '25 View

Archrock Inc. AROC reported second-quarter 2025 earnings per share of 39 cents, which beat the Zacks Consensus Estimate of 37 cents. The bottom line improved from the year-ago quarter’s level of 25

JPMorgan and Carter's have been highlighted as Zacks Bull and Bear of the Day
JPMorgan and Carter's have been highlighted as Zacks Bull and Bear of the Day

For Immediate Release

Chicago, IL – August 6, 2025 – Zacks Equity Research shares JPMorgan JPM as the Bull of the Day and Carter’s Inc. CRI as the Bear of the Day. In addition, Zacks Equity Research

Here's How Much You'd Have If You Invested $1000 in Monolithic Power a Decade Ago
Here's How Much You'd Have If You Invested $1000 in Monolithic Power a Decade Ago

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

If You Invested $1000 in Generac Holdings a Decade Ago, This is How Much It'd Be Worth Now
If You Invested $1000 in Generac Holdings a Decade Ago, This is How Much It'd Be Worth Now

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

1stdibs.com (DIBS) Reports Q2 Loss, Tops Revenue Estimates
1stdibs.com (DIBS) Reports Q2 Loss, Tops Revenue Estimates

1stdibs.com (DIBS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.12 per share a year ago. These figures are

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Tops Revenue Estimates
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Tops Revenue Estimates

NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.51 per share a year